Tuberculosis and Chronic Hepatitis B Virus Infection Screening Among Non-US–Born Persons in an Integrated Health System in California
Among non-US-born persons from countries with high TB and HBV burden, we found low screening rates and elevated prevalence of TBI and chronic HBV infection. Cotesting for TBI and HBV infection in non-US-born persons from countries with high TB and HBV burden might improve outcomes by identifying persons who warrant TBI treatment, HBV treatment, or HBV vaccination. Increased screening is the first step in reducing health inequities and overall disease burden.
Authors
- Amit S. Chitnis
- Amy Krueger (ORCID: https://orcid.org/0000-0002-9803-8087)
- Robert J. Wong (ORCID: https://orcid.org/0000-0002-8923-2806)
- Devan Jaganath (ORCID: https://orcid.org/0000-0002-8555-5667)
- Jacek Skarbinski (ORCID: https://orcid.org/0000-0003-1630-5733)
- Nicole Halmer
- Jenna Maco Wick (ORCID: https://orcid.org/0009-0001-0031-1832)
- Yuching Ni
Institutions
- Centers for Disease Control and Prevention (US)
- Kaiser Permanente (US)
- University of California, San Francisco (US)
- VA Palo Alto Health Care System (US)
- Kaiser Permanente Oakland Medical Center (US)
- Alameda County Public Health Department (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- Stanford University (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1093/ofid/ofae484
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39